Drug Information for Patients

Explore the tabs on the left to learn more about how Prostate Cancer Canada and patients are involved in the pan-Canadian Oncology Drug Review (pCODR), and to learn more about Patient Choice Cards, which are programs that can help with access brand name medications.
 
And, if you’re wondering about how drugs  are approved for patient use in Canada, check out the video below by Policy Matters Canada.
 
     pCODR     
 

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive